doi: 10.1146/annurev-animal-020420-031544 7 GriffithOWChavanARProtopapasSMaziarzJRomeroRWagnerGP
GLP-1 receptor agonists can increase dopamine release in the mesolimbic pathway, ultimately increasing baseline dopamine levels and reducing the spike that leads to cravings, he said
It also has no notable impact on BMI, systolic, or diastolic blood pressure in this population
This is especially important if your formulation comes in a clear glass vial rather than an amber one
Instead, CMS is extending the duration of a separate short-term program, called the Medicare GLP-1 Bridge, which was originally scheduled to run from July-December 2026 but will now run through the end of 2027
General Guidelines for Alcohol Use During Peptide Therapy While recommendations vary depending on the specific peptide and individual health, these general guidelines can help: Avoid alcohol during initial treatment phase The first few weeks of peptide therapy are critical for establishing treatment effects